Goldman Sachs’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-47,260
| Closed | -$1.01M | – | 4985 |
|
|
2024
Q1 | $1.01M | Buy |
47,260
+32,128
| +212% | +$685K | ﹤0.01% | 3616 |
|
|
2023
Q4 | $145K | Buy |
+15,132
| New | +$145K | ﹤0.01% | 4401 |
|
|
2021
Q4 | – | Sell |
-20,149
| Closed | -$160K | – | 5722 |
|
|
2021
Q3 | $160K | Buy |
20,149
+1,928
| +11% | +$15.3K | ﹤0.01% | 4940 |
|
|
2021
Q2 | $147K | Buy |
18,221
+4,149
| +29% | +$33.5K | ﹤0.01% | 5030 |
|
|
2021
Q1 | $151K | Sell |
14,072
-85
| -0.6% | -$912 | ﹤0.01% | 4931 |
|
|
2020
Q4 | $166K | Buy |
+14,157
| New | +$166K | ﹤0.01% | 4334 |
|